|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
217 Portobello, Sheffield, South Yorkshire S1 4DP, GB
|
|
Rinri Therapeutics is a private biotechnology company developing first-in-class cell therapies to restore hearing. Hearing loss affects 350m people in the world; 90% caused by sensorineural hearing loss (SNHL). There are currently no disease-modifying therapeutics for SNHL patients. Rinri's pioneering technology seeks to reverse SNHL through the regeneration of the damaged sensory cells in the inner ear, the cochlea. Rinri is backed by Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, BioCity and the University of Sheffield.
|
Rinri Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Rinri Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Rinri Therapeutics customer service number in your country click here to find.
Simon Chandler is the CEO of Rinri Therapeutics. To contact Simon Chandler email at [email protected], [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.